New health education website launched | Inquirer Technology

New health education website launched

03:34 PM September 13, 2012

A new health education website,, sponsored by Gilead Sciences, Inc., intended for audiences in the United States, is now online.

Launched last September 7, contains practical information about chronic hepatitis B (CHB), a potentially life-threatening liver disease that affects an estimated two million people in the United States and is the leading cause of liver cancer.


Chronic hepatitis B is caused by a virus and can slowly damage the liver, without causing obvious symptoms.  Chronic hepatitis B can be diagnosed with a simple blood test, prevented with a vaccine, and managed with appropriate care – but alarmingly, most people living with the disease don’t know they are infected.

Without treatment, 1 in 4 people with CHB may die of disease-related complications. The impact of chronic hepatitis B in the United States is more severe among Asian American communities.


•             Information on how to prevent CHB, testing for the disease, and management of CHB.

•             An innovative animated video depicting a CHB patient’s journey from diagnosis to care (available in 14 languages with subtitles).

•             Educational brochures in 14 languages, including Chinese, Korean, Vietnamese, and Tagalog among others. is an educational website created by Gilead Sciences, a maker of medicines for chronic hepatitis B.  The website is part of Gilead’s ongoing effort to raise community awareness of chronic hepatitis B.

The latest tech news delivered to your inbox

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.
TOPICS: Gilead Sciences, health education website, Inc., infotech, Internet, News
Read Next
Don't miss out on the latest news and information.

Subscribe to INQUIRER PLUS to get access to The Philippine Daily Inquirer & other 70+ titles, share up to 5 gadgets, listen to the news, download as early as 4am & share articles on social media. Call 896 6000.

For feedback, complaints, or inquiries, contact us.

Subscribe to our technology news

By providing an email address. I agree to the Terms of Use and
acknowledge that I have read the Privacy Policy.

© Copyright 1997-2021 | All Rights Reserved

We use cookies to ensure you get the best experience on our website. By continuing, you are agreeing to our use of cookies. To find out more, please click this link.